MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Diabetes (Glucometers, Glucose Monitoring, Continuous Glucose Monitoring [CGM] Companies)
Echo Therapeutics Inc (NASDAQ:ECTE)
Parents
*Architects: Diabetes (Glucometers, Glucose Monitoring, Continuous Glucose Monitoring [CGM] Companies)
*Architects: Drug Delivery (Transdermal Patches_Microneedles)
*Industry: Massachusetts
2014: 15 Game-Changing Wireless Devices to Improve Patient Care_Medscape
Children
Echo Therapeutics (ECTE) Posts Positive Clinical Results for Needle-free Glucose Monitoring System (2011)
Echo Therapeutics Announces $20 Million Financing WITH With Platinum-Montaur Life Sciences (2012)
Echo Therapeutics gets $10M from licensing deal and stock sale (2013)
Echo Therapeutics Non-Invasive Glucometer and Skin Permeation System Demonstrated (2011)
Franklin, Massachusetts
Glucose monitor gives continuous reading with needle-free technology (2012)
Submitted Prelude SkinPrep System™ and 4% lidocaine cream to the FDA for 510(k) clearance.(2010)
The Symphony tCGM System™ is a non-invasive (needle-free), wireless, transdermal continuous glucose monitoring system which will provide accurate, real-time blood glucose data conveniently, continuously, and affordably in an ambulatory environment or a cri
Transdermal medical device company